UBS Group’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,200
Closed -$254K 11315
2025
Q4
$254K Hold
3,200
﹤0.01% 6457
2025
Q3
$234K Buy
+3,200
New +$235K ﹤0.01% 6583

Other funds holding SOLV

UBS Group's SOLV Position: Q1 2026 in Review

UBS Group reduced its Solventum (SOLV) stake by 15% in Q1 2026, selling an estimated $8.53M and leaving 632,974 shares worth $41.3M. The position accounts for 0.01% of the portfolio, ranked #1839.

UBS Group first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $59.3M in Q4 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • UBS Group held 632,974 shares of Solventum worth $41.3M as of Q1 2026.
  • UBS Group sold 114,898 Solventum shares in Q1 2026, an estimated $8.53M.
  • Solventum made up 0.01% of UBS Group's portfolio in Q1 2026, its #1839 holding.
  • UBS Group first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • UBS Group's Solventum position peaked at $59.3M in Q4 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.